For patients with T3/T4 and Tany N-positive anal cancer, the use of radiotherapy dose escalation from 53.2 Gy to 58.8 Gy or 61.6 Gy in 28 fractions did not improve outcomes at 6 months, according to results from the phase 3 PLATO ACT 5 trial…

For patients with T3/T4 and Tany N-positive anal cancer, the use of radiotherapy dose escalation from 53.2 Gy to 58.8 Gy or 61.6 Gy in 28 fractions did not improve outcomes at 6 months, according to results from the phase 3 PLATO ACT 5 trial…